 | • レポートコード：GIR201115313 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：機械・機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、結核診断・治療の世界市場を調査対象にし、結核診断・治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（皮膚テスト、実験室テスト）、用途別分析（病院、診療所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Cepheid Inc、bioMerieux、Abbott Laboratories、Becton Dickinson、Hologic Corporation、Hain LifeSciences、QIAGEN、Roche AG、Alere, Inc、Sanofi、Thermo Fisher Scientific, Inc、Akonni Biosystems, Inc.、EIKEN Chemical、Epistem Holdings Plc、Gen-Probe Inc. ・企業別売上、市場シェア ・結核診断・治療の地域別市場分析 ・結核診断・治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・結核診断・治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・結核診断・治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・結核診断・治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・結核診断・治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・結核診断・治療の種類別市場規模2015-2020：皮膚テスト、実験室テスト ・結核診断・治療の用途別市場規模2015-2020：病院、診療所、その他 ・結核診断・治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Tuberculosis Diagnostics and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tuberculosis Diagnostics and Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tuberculosis Diagnostics and Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tuberculosis Diagnostics and Treatment market has been segmented into:
Skin Testing
Laboratory Testing
By Application, Tuberculosis Diagnostics and Treatment has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tuberculosis Diagnostics and Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Tuberculosis Diagnostics and Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tuberculosis Diagnostics and Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Tuberculosis Diagnostics and Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tuberculosis Diagnostics and Treatment Market Share Analysis
Tuberculosis Diagnostics and Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tuberculosis Diagnostics and Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tuberculosis Diagnostics and Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Tuberculosis Diagnostics and Treatment are:
Cepheid Inc
bioMerieux
Abbott Laboratories
Becton Dickinson
Hologic Corporation
Hain LifeSciences
QIAGEN
Roche AG
Alere, Inc
Sanofi
Thermo Fisher Scientific, Inc
Akonni Biosystems, Inc.
EIKEN Chemical
Epistem Holdings Plc
Gen-Probe Inc.
1 Tuberculosis Diagnostics and Treatment Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnostics and Treatment
1.2 Classification of Tuberculosis Diagnostics and Treatment by Type
1.2.1 Global Tuberculosis Diagnostics and Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type in 2019
1.2.3 Skin Testing
1.2.4 Laboratory Testing
1.3 Global Tuberculosis Diagnostics and Treatment Market by Application
1.3.1 Overview: Global Tuberculosis Diagnostics and Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tuberculosis Diagnostics and Treatment Market by Regions
1.4.1 Global Tuberculosis Diagnostics and Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tuberculosis Diagnostics and Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tuberculosis Diagnostics and Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Diagnostics and Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Diagnostics and Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tuberculosis Diagnostics and Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Diagnostics and Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Cepheid Inc
2.1.1 Cepheid Inc Details
2.1.2 Cepheid Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cepheid Inc SWOT Analysis
2.1.4 Cepheid Inc Product and Services
2.1.5 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 bioMerieux
2.2.1 bioMerieux Details
2.2.2 bioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 bioMerieux SWOT Analysis
2.2.4 bioMerieux Product and Services
2.2.5 bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories SWOT Analysis
2.3.4 Abbott Laboratories Product and Services
2.3.5 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Becton Dickinson
2.4.1 Becton Dickinson Details
2.4.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Becton Dickinson SWOT Analysis
2.4.4 Becton Dickinson Product and Services
2.4.5 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hologic Corporation
2.5.1 Hologic Corporation Details
2.5.2 Hologic Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hologic Corporation SWOT Analysis
2.5.4 Hologic Corporation Product and Services
2.5.5 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hain LifeSciences
2.6.1 Hain LifeSciences Details
2.6.2 Hain LifeSciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hain LifeSciences SWOT Analysis
2.6.4 Hain LifeSciences Product and Services
2.6.5 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 QIAGEN SWOT Analysis
2.7.4 QIAGEN Product and Services
2.7.5 QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche AG
2.8.1 Roche AG Details
2.8.2 Roche AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche AG SWOT Analysis
2.8.4 Roche AG Product and Services
2.8.5 Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Alere, Inc
2.9.1 Alere, Inc Details
2.9.2 Alere, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Alere, Inc SWOT Analysis
2.9.4 Alere, Inc Product and Services
2.9.5 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi SWOT Analysis
2.10.4 Sanofi Product and Services
2.10.5 Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Thermo Fisher Scientific, Inc
2.11.1 Thermo Fisher Scientific, Inc Details
2.11.2 Thermo Fisher Scientific, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Thermo Fisher Scientific, Inc SWOT Analysis
2.11.4 Thermo Fisher Scientific, Inc Product and Services
2.11.5 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Akonni Biosystems, Inc.
2.12.1 Akonni Biosystems, Inc. Details
2.12.2 Akonni Biosystems, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Akonni Biosystems, Inc. SWOT Analysis
2.12.4 Akonni Biosystems, Inc. Product and Services
2.12.5 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 EIKEN Chemical
2.13.1 EIKEN Chemical Details
2.13.2 EIKEN Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 EIKEN Chemical SWOT Analysis
2.13.4 EIKEN Chemical Product and Services
2.13.5 EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Epistem Holdings Plc
2.14.1 Epistem Holdings Plc Details
2.14.2 Epistem Holdings Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Epistem Holdings Plc SWOT Analysis
2.14.4 Epistem Holdings Plc Product and Services
2.14.5 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Gen-Probe Inc.
2.15.1 Gen-Probe Inc. Details
2.15.2 Gen-Probe Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Gen-Probe Inc. SWOT Analysis
2.15.4 Gen-Probe Inc. Product and Services
2.15.5 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tuberculosis Diagnostics and Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Diagnostics and Treatment Players Market Share
3.2.2 Top 10 Tuberculosis Diagnostics and Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tuberculosis Diagnostics and Treatment Revenue and Market Share by Regions
4.2 North America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
5 North America Tuberculosis Diagnostics and Treatment Revenue by Countries
5.1 North America Tuberculosis Diagnostics and Treatment Revenue by Countries (2015-2020)
5.2 USA Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
6 Europe Tuberculosis Diagnostics and Treatment Revenue by Countries
6.1 Europe Tuberculosis Diagnostics and Treatment Revenue by Countries (2015-2020)
6.2 Germany Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
6.4 France Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Countries
7.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Countries (2015-2020)
7.2 China Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
7.5 India Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
8 South America Tuberculosis Diagnostics and Treatment Revenue by Countries
8.1 South America Tuberculosis Diagnostics and Treatment Revenue by Countries (2015-2020)
8.2 Brazil Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tuberculosis Diagnostics and Treatment by Countries
9.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tuberculosis Diagnostics and Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Type (2019-2024)
10.3 Skin Testing Revenue Growth Rate (2015-2025)
10.4 Laboratory Testing Revenue Growth Rate (2015-2025)
11 Global Tuberculosis Diagnostics and Treatment Market Segment by Application
11.1 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2015-2020)
11.2 Tuberculosis Diagnostics and Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Tuberculosis Diagnostics and Treatment Market Size Forecast (2021-2025)
12.1 Global Tuberculosis Diagnostics and Treatment Market Size Forecast (2021-2025)
12.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Regions (2021-2025)
12.3 North America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
12.6 South America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tuberculosis Diagnostics and Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tuberculosis Diagnostics and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tuberculosis Diagnostics and Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tuberculosis Diagnostics and Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Cepheid Inc Corporate Information, Location and Competitors
Table 6. Cepheid Inc Tuberculosis Diagnostics and Treatment Major Business
Table 7. Cepheid Inc Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Cepheid Inc SWOT Analysis
Table 9. Cepheid Inc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 10. Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. bioMerieux Corporate Information, Location and Competitors
Table 12. bioMerieux Tuberculosis Diagnostics and Treatment Major Business
Table 13. bioMerieux Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2018-2019)
Table 14. bioMerieux SWOT Analysis
Table 15. bioMerieux Tuberculosis Diagnostics and Treatment Product and Solutions
Table 16. bioMerieux Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbott Laboratories Corporate Information, Location and Competitors
Table 18. Abbott Laboratories Tuberculosis Diagnostics and Treatment Major Business
Table 19. Abbott Laboratories Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Abbott Laboratories SWOT Analysis
Table 21. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product and Solutions
Table 22. Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Becton Dickinson Corporate Information, Location and Competitors
Table 24. Becton Dickinson Tuberculosis Diagnostics and Treatment Major Business
Table 25. Becton Dickinson Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Becton Dickinson SWOT Analysis
Table 27. Becton Dickinson Tuberculosis Diagnostics and Treatment Product and Solutions
Table 28. Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hologic Corporation Corporate Information, Location and Competitors
Table 30. Hologic Corporation Tuberculosis Diagnostics and Treatment Major Business
Table 31. Hologic Corporation Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Hologic Corporation SWOT Analysis
Table 33. Hologic Corporation Tuberculosis Diagnostics and Treatment Product and Solutions
Table 34. Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Hain LifeSciences Corporate Information, Location and Competitors
Table 36. Hain LifeSciences Tuberculosis Diagnostics and Treatment Major Business
Table 37. Hain LifeSciences Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Hain LifeSciences SWOT Analysis
Table 39. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product and Solutions
Table 40. Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. QIAGEN Corporate Information, Location and Competitors
Table 42. QIAGEN Tuberculosis Diagnostics and Treatment Major Business
Table 43. QIAGEN Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 44. QIAGEN SWOT Analysis
Table 45. QIAGEN Tuberculosis Diagnostics and Treatment Product and Solutions
Table 46. QIAGEN Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Roche AG Corporate Information, Location and Competitors
Table 48. Roche AG Tuberculosis Diagnostics and Treatment Major Business
Table 49. Roche AG Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Roche AG SWOT Analysis
Table 51. Roche AG Tuberculosis Diagnostics and Treatment Product and Solutions
Table 52. Roche AG Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Alere, Inc Corporate Information, Location and Competitors
Table 54. Alere, Inc Tuberculosis Diagnostics and Treatment Major Business
Table 55. Alere, Inc Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Alere, Inc SWOT Analysis
Table 57. Alere, Inc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 58. Alere, Inc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sanofi Corporate Information, Location and Competitors
Table 60. Sanofi Tuberculosis Diagnostics and Treatment Major Business
Table 61. Sanofi Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Sanofi SWOT Analysis
Table 63. Sanofi Tuberculosis Diagnostics and Treatment Product and Solutions
Table 64. Sanofi Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Thermo Fisher Scientific, Inc Corporate Information, Location and Competitors
Table 66. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Major Business
Table 67. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Thermo Fisher Scientific, Inc SWOT Analysis
Table 69. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 70. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Akonni Biosystems, Inc. Corporate Information, Location and Competitors
Table 72. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Major Business
Table 73. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Akonni Biosystems, Inc. SWOT Analysis
Table 75. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product and Solutions
Table 76. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. EIKEN Chemical Corporate Information, Location and Competitors
Table 78. EIKEN Chemical Tuberculosis Diagnostics and Treatment Major Business
Table 79. EIKEN Chemical Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 80. EIKEN Chemical SWOT Analysis
Table 81. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product and Solutions
Table 82. EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Epistem Holdings Plc Corporate Information, Location and Competitors
Table 84. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Major Business
Table 85. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Epistem Holdings Plc SWOT Analysis
Table 87. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 88. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Gen-Probe Inc. Corporate Information, Location and Competitors
Table 90. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Major Business
Table 91. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Gen-Probe Inc. SWOT Analysis
Table 93. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product and Solutions
Table 94. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Players (2015-2020)
Table 96. Global Tuberculosis Diagnostics and Treatment Revenue Share by Players (2015-2020)
Table 97. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Regions (2015-2020)
Table 99. North America Tuberculosis Diagnostics and Treatment Revenue by Countries (2015-2020)
Table 100. North America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Table 101. Europe Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Tuberculosis Diagnostics and Treatment Revenue by Countries (2015-2020)
Table 104. South America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Table 107. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Type (2015-2020)
Table 108. Global Tuberculosis Diagnostics and Treatment Revenue Share by Type (2015-2020)
Table 109. Global Tuberculosis Diagnostics and Treatment Revenue Forecast by Type (2021-2025)
Table 110. Global Tuberculosis Diagnostics and Treatment Revenue by Application (2015-2020)
Table 111. Global Tuberculosis Diagnostics and Treatment Revenue Share by Application (2015-2020)
Table 112. Global Tuberculosis Diagnostics and Treatment Revenue Forecast by Application (2021-2025)
Table 113. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tuberculosis Diagnostics and Treatment Picture
Figure 2. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type in 2019
Figure 3. Skin Testing Picture
Figure 4. Laboratory Testing Picture
Figure 5. Tuberculosis Diagnostics and Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Tuberculosis Diagnostics and Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Tuberculosis Diagnostics and Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Tuberculosis Diagnostics and Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Tuberculosis Diagnostics and Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2019
Figure 42. China Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Tuberculosis Diagnostics and Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Tuberculosis Diagnostics and Treatment Revenue Share by Type in 2019
Figure 59. Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Skin Testing Revenue Growth Rate (2015-2020)
Figure 61. Global Laboratory Testing Revenue Growth Rate (2015-2020)
Figure 62. Global Tuberculosis Diagnostics and Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Tuberculosis Diagnostics and Treatment Revenue Share by Application in 2019
Figure 64. Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Tuberculosis Diagnostics and Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
結核診断の世界市場 2020年 Market Overview The Tuberculosis Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- 胃がん検査・治療・予防の世界市場 2020年 Market Overview The global Gastric Cancer Testing, Treatment and Prevention market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- 人獣共通感染症治療の世界市場 2020年 Market Overview The global Zoonotic Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Zoonotic Disease T…
- 緑内障治療装置の世界市場 2020年 Market Overview The global Glaucoma Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Treatment…
- POC診断の世界市場 2020年 Market Overview The POC Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…